Age at diagnosis, yrs, mean ± SD | |
Male | 58.5 ± 19.8 |
Female | 57.8 ± 18.9 |
All | 58.2 ± 19.4 |
Age, male, yrs, n (%) | |
0–9 | 313 (2.2) |
10–19 | 497 (3.5) |
20–29 | 626 (4.4) |
30–39 | 1016 (7.1) |
40–49 | 1745 (12.2) |
50–59 | 2520 (17.6) |
60–69 | 2770 (19.4) |
70–79 | 3144 (22.0) |
≥ 80 | 1660 (11.6) |
All | 14,291 (100) |
Age, female, yrs, n (%) | |
0–9 | 198 (1.8) |
10–19 | 254 (2.4) |
20–29 | 549 (5.1) |
30–39 | 828 (7.7) |
40–49 | 1491 (13.8) |
50–59 | 2033 (18.9) |
60–69 | 2235 (20.7) |
70–79 | 2106 (19.5) |
≥ 80 | 1089 (10.1) |
All | 10,783 (100) |
Duration of followup, yrs, mean ± SD | |
Male | 6.7 ± 4.8 |
Female | 6.6 ± 4.7 |
All | 6.6 ± 4.8 |